BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9885410)

  • 1. Drug monitoring of orally administered 8-methoxypsoralen in patients treated with extracorporeal photopheresis.
    Balogh A; Merkel U; Looks A; Vollandt R; Wollina U
    Skin Pharmacol Appl Skin Physiol; 1998; 11(4-5):258-65. PubMed ID: 9885410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and buffy coat concentration of 8-methoxypsoralen in patients treated with extracorporeal photopheresis.
    Balogh A; Merkel U; Looks A; Vollandt R; Wollina U
    Exp Toxicol Pathol; 1998 Sep; 50(4-6):397-401. PubMed ID: 9784014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of 8-methoxypsoralen during extracorporeal photopheresis.
    Shephard SE; Nestle FO; Panizzon R
    Photodermatol Photoimmunol Photomed; 1999 Apr; 15(2):64-74. PubMed ID: 10321518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison between 8-methoxypsoralen and 5-aminolevulinic acid in killing T cells of photopheresis patients ex vivo.
    Holien T; Gederaas OA; Darvekar SR; Christensen E; Peng Q
    Lasers Surg Med; 2018 Jul; 50(5):469-475. PubMed ID: 29460964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis induction by extracorporeal photopheresis is enhanced by increasing the 8-methoxypsoralen concentration and by replacing plasma with saline.
    Hähnel V; Brosig AM; Ehrenschwender M; Burkhardt R; Offner R; Ahrens N
    Transfusion; 2021 Oct; 61(10):2991-2999. PubMed ID: 34427336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of 8-methoxypsoralen during extracorporeal photochemotherapy: evidence for a "first-dose" effect.
    Jacolot A; Tod M; Heudes AM; Petitjean O; Laroche L
    Ther Drug Monit; 1996 Jun; 18(3):234-9. PubMed ID: 8738761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The North American experience with photopheresis.
    Zic JA; Miller JL; Stricklin GP; King LE
    Ther Apher; 1999 Feb; 3(1):50-62. PubMed ID: 10079806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal Photopheresis in the Treatment of Mycosis Fungoides and Sézary Syndrome.
    Zic JA
    Dermatol Clin; 2015 Oct; 33(4):765-76. PubMed ID: 26433848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High plasma levels of 8-methoxypsoralen following bath water delivery in dermatological patients.
    Kappes UP; Barta U; Merkel U; Balogh A; Elsner P
    Skin Pharmacol Appl Skin Physiol; 2003; 16(5):305-12. PubMed ID: 12907835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of extracorporeal photopheresis technology with porphyrin precursors. Comparison between 8-methoxypsoralen and hexaminolevulinate in killing human T-cell lymphoma cell lines in vitro.
    Cunderlíková B; Vasovič V; Randeberg LL; Christensen E; Warloe T; Nesland JM; Peng Q
    Biochim Biophys Acta; 2014 Sep; 1840(9):2702-8. PubMed ID: 24915603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of metoclopramide on the pharmacokinetics of 8-methoxypsoralen.
    Studer-Sachsenberg EM; Piletta PA; Fathi M; Saurat JH; Salomon D
    Dermatology; 1997; 195(1):81-3. PubMed ID: 9267751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method for the quantification of 8-methoxypsoralen by mass spectrometry for offline extracorporeal photopheresis.
    Hähnel V; Dormann F; Nitsopoulos A; Friedle A; Ahrens N
    Photochem Photobiol Sci; 2017 Feb; 16(2):193-200. PubMed ID: 27976780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal toxic reactions following photopheresis.
    Vagace JM; Gervasini G; Morais F; Benitez J; Alonso N; de Argila D; Arranz I; Bajo R
    Arch Dermatol; 2007 May; 143(5):622-5. PubMed ID: 17515512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A standardized methodical approach to characterize the influence of key parameters on the in vitro efficacy of extracorporeal photopheresis.
    Laulhé M; Lefebvre S; Le Broc-Ryckewaert D; Pierre M; Ferry A; Delorme B
    PLoS One; 2019; 14(3):e0212835. PubMed ID: 30822323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parenteral administration of 8-methoxypsoralen in photopheresis.
    Knobler RM; Trautinger F; Graninger W; Macheiner W; Gruenwald C; Neumann R; Ramer W
    J Am Acad Dermatol; 1993 Apr; 28(4):580-4. PubMed ID: 8463458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photopheresis in cutaneous T-cell lymphoma: five-year experience.
    Crovetti G; Carabelli A; Berti E; Guizzardi M; Fossati S; De Filippo C; Bertani E
    Int J Artif Organs; 2000 Jan; 23(1):55-62. PubMed ID: 12118838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photopheresis (extracorporeal photochemotherapy).
    Trautinger F; Just U; Knobler R
    Photochem Photobiol Sci; 2013 Jan; 12(1):22-8. PubMed ID: 22859214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix-dependent absorption of 8-methoxypsoralen in extracorporeal photopheresis.
    Hähnel V; Weber I; Tuemmler S; Graf B; Gruber M; Burkhardt R; Ahrens N
    Photochem Photobiol Sci; 2020 Aug; 19(8):1099-1103. PubMed ID: 32638713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal methoxsalen: new drug. Cutaneous T cell lymphoma: for rare patients, but better assessment needed.
    Prescrire Int; 2009 Feb; 18(99):16. PubMed ID: 19388212
    [No Abstract]   [Full Text] [Related]  

  • 20. Mini buffy coat photopheresis for children and critically ill patients with extracorporeal photopheresis contraindications.
    Hackstein H; Misterek J; Nockher A; Reiter A; Bein G; Woessmann W
    Transfusion; 2009 Nov; 49(11):2366-73. PubMed ID: 19903292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.